BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Diabetes mellitus
,
Liver
,
Human chorionic gonadotropin
,
Doxycycline
,
rs6983267
,
EGFR
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
isoniazid
Summary
General Info
Curated Studies
Most Correlated Studies
Tuberculosis patients' blood gene expression profiles throughout standard treatment
Lungs of BALB/c mice with tuberculosis treated with DNA-hsp65, isoniazid/rifampicin, or both
Precision cut liver slices treated 24 hours with acetaminophen, isoniazid, or paraquat
Hepatocellular carcinoma HepG2 cells treated with hepatotoxic or non-hepatotoxic compounds
Livers from mice treated with acetaminophen, isoniazid or paraquat
Explore Curated Studies Results
Literature
Most Relevant Literature
Determination of ionization constant and drug-likeness prediction of synthetic isoniazid derivatives…
Mixed methods systematic review and metasummary about barriers and facilitators for the implementati…
Green synthesis of CQDs for determination of iron and isoniazid in pharmaceutical formulations.
Efficacy, safety, and tolerability of isoniazid preventive therapy for tuberculosis in people living…
Barriers and Facilitators of Isoniazid Preventive Therapy Implementation among People Living with HI…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pharmacogenetics-guided Isoniazid Dosing in TB-HIV
Pharmacokinetics of Efavirenz in the Presence of Rifampicin and Isoniazid
TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment
Treatment of Latent Tuberculosis Infection With Isoniazid
Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis Prevention
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ